|
TGDS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.179700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.438000E-02 |
| Normal-vs-Stage2 |
1.136040E-01 |
| Normal-vs-Stage3 |
2.923600E-01 |
| Normal-vs-Stage4 |
1.867440E-01 |
| Stage1-vs-Stage2 |
4.658000E-01 |
| Stage1-vs-Stage3 |
8.700200E-01 |
| Stage1-vs-Stage4 |
6.782800E-01 |
| Stage2-vs-Stage3 |
6.526600E-01 |
| Stage2-vs-Stage4 |
9.001800E-01 |
| Stage3-vs-Stage4 |
7.959000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.903900E-03 |
| Normal-vs-AfricanAmerican |
1.866590E-01 |
| Normal-vs-Asian |
8.733400E-01 |
| Caucasian-vs-AfricanAmerican |
5.373200E-01 |
| Caucasian-vs-Asian |
4.411600E-01 |
| AfricanAmerican-vs-Asian |
5.700000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.676200E-02 |
| Normal-vs-Female |
3.276200E-02 |
| Male-vs-Female |
4.982800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.917200E-01 |
| Normal-vs-Extreme_Weight |
1.459020E-01 |
| Normal-vs-Obese |
3.876300E-02 |
| Normal-vs-Extreme_Obese |
2.898800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.078800E-01 |
| Normal_Weight-vs-Obese |
3.180800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.415400E-01 |
| Extreme_Weight-vs-Obese |
4.603600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.926000E-01 |
| Obese-vs-Extreme_Obese |
8.871200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.326000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.518140E-03 |
| Normal-vs-Age(61-80Yrs) |
1.399840E-01 |
| Normal-vs-Age(81-100Yrs) |
6.054000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.953900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.552400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.973400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.857800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.576200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.757400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.417000E-03 |
| Normal-VS-Type2 PRCC |
1.469990E-01 |
| Normal-VS-KIRP CIMP |
2.908000E-01 |
| Normal-VS-Unclassified PRCC |
2.123600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.734000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.860400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.887600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.545180E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.454000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.317170E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.754000E-01 |
| Normal-vs-N1 |
2.302600E-01 |
| Normal-vs-N2 |
1.742160E-01 |
| N0-vs-N1 |
3.542400E-01 |
| N0-vs-N2 |
3.310400E-01 |
| N1-vs-N2 |
2.851200E-01 |
|
|
